share_log

UnitedHealth | 3: Initial statement of beneficial ownership of securities-Officer Cianfrocco Heather

UnitedHealth | 3: Initial statement of beneficial ownership of securities

聯合健康 | 3:首次持股聲明
SEC announcement ·  04/04 04:23
牛牛AI助理已提取核心訊息
Heather Cianfrocco, an executive at UnitedHealth Group Incorporated, filed an initial statement of beneficial ownership with the SEC on April 1, 2024, as required by Section 16(a) of the Securities Exchange Act of 1934. The filing indicates that Cianfrocco beneficially owns 17,063.885 shares of UnitedHealth common stock directly. Additionally, the executive holds various non-qualified stock options to buy additional shares of UnitedHealth common stock, with expiration dates ranging from 2027 to 2034 and exercise prices between $160.31 and $521.97. These options have vested or will vest at a rate of 25% annually over several years, according to the specific terms of each option grant. The filing was completed solely by Cianfrocco, without amendments, and does not involve joint or group filing.
Heather Cianfrocco, an executive at UnitedHealth Group Incorporated, filed an initial statement of beneficial ownership with the SEC on April 1, 2024, as required by Section 16(a) of the Securities Exchange Act of 1934. The filing indicates that Cianfrocco beneficially owns 17,063.885 shares of UnitedHealth common stock directly. Additionally, the executive holds various non-qualified stock options to buy additional shares of UnitedHealth common stock, with expiration dates ranging from 2027 to 2034 and exercise prices between $160.31 and $521.97. These options have vested or will vest at a rate of 25% annually over several years, according to the specific terms of each option grant. The filing was completed solely by Cianfrocco, without amendments, and does not involve joint or group filing.
根據1934年《證券交易法》第16(a)條的要求,UnitedHealth Group Incorporated的高管希瑟·錢弗羅科於2024年4月1日向美國證券交易委員會提交了初步的實益所有權聲明。該文件顯示,Cianfrocco直接實益擁有17,063.885股UnitedHealth普通股。此外,該高管持有各種非合格股票期權,可以額外購買UnitedHealth普通股,到期日從2027年到2034年不等,行使價在160.31美元至521.97美元之間。根據每份期權授予的具體條款,這些期權已經或將在幾年內以每年25%的利率歸屬。該文件僅由Cianfrocco完成,未經修改,不涉及聯合或集體申報。
根據1934年《證券交易法》第16(a)條的要求,UnitedHealth Group Incorporated的高管希瑟·錢弗羅科於2024年4月1日向美國證券交易委員會提交了初步的實益所有權聲明。該文件顯示,Cianfrocco直接實益擁有17,063.885股UnitedHealth普通股。此外,該高管持有各種非合格股票期權,可以額外購買UnitedHealth普通股,到期日從2027年到2034年不等,行使價在160.31美元至521.97美元之間。根據每份期權授予的具體條款,這些期權已經或將在幾年內以每年25%的利率歸屬。該文件僅由Cianfrocco完成,未經修改,不涉及聯合或集體申報。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。